ArticleFrontiers in immunology2023

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.

Brandon Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.